Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| INTEGRA LIFESCIENCES HOLDINGS CORPIART · Entity 2707 | 10% owner | June 18, 2020 | June 22, 2020 |
| SeaSpine Holdings CorpSPNE · Entity 120832 | 10% owner | April 29, 2020 | May 01, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
INTEGRA LIFESCIENCES HOLDINGS CORP
Report date June 18, 2020 · Filed June 22, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy Partnership | 10,291,205 |
Reported balance
After 2020-06-18 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2020-06-18 · Sale · Disposed 600,000 · Balance 10,291,205 F1: Trust Partnership contributed Issuer common stock to an exchange fund in exchange for shares of the exchange fund. The Issuer common stock was valued at $48.57 per share for the purpose of determining the number of shares of the exchange fund issuable to Trust Partnership. |
| Common StockSEC Table I · non-derivative | Direct | 163,668 |
Reported balance
Holding disclosure · report date 2020-06-18 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 163,668 |
| Common StockSEC Table I · non-derivative | IndirectBy Son | 4,000 |
Reported balance
Holding disclosure · report date 2020-06-18 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 4,000 |
Filing footnotes · ownership attribution and instrument terms
F1: Trust Partnership contributed Issuer common stock to an exchange fund in exchange for shares of the exchange fund. The Issuer common stock was valued at $48.57 per share for the purpose of determining the number of shares of the exchange fund issuable to Trust Partnership.
SeaSpine Holdings Corp
Report date April 29, 2020 · Filed May 01, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 15,457 |
Ending reported balance
After 2020-04-29 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2020-04-29 · Other · Acquired 4,921 · Balance 20,378 Row 2 · 2020-04-29 · Sale · Disposed 4,921 · Balance 15,457 |
| Stock Option (Right-to-Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $9.43 · Expires 2020-05-15 | Direct | 0 |
Reported balance
After 2020-04-29 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2020-04-29 · Other · Disposed 4,921 · Balance 0 |
| Common StockSEC Table I · non-derivative | IndirectBy Tru St Partnership LP | 1,997,068 |
Reported balance
Holding disclosure · report date 2020-04-29 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 1,997,068 F1: The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. F2: Tru St Partnership, LP ("Tru St") may be deemed the beneficial owner of 1,997,068 shares of common stock. Dr. Caruso is the Chairman Emeritus of Provco Leasing Corporation ("Provco Leasing"). Provco Leasing is the corporate general partner of Tru St Partnership LP. Provco Leasing owns 7,779 shares of common stock directly and is the beneficial owner of 2,004,847 shares of common stock. The Uncommon Individual Foundation is the beneficial owner of 24,382 shares of common stock as of December 31, 2018. Dr. Caruso is the founder and chief executive officer of The Uncommon Individual Foundation. At the quarterly board meeting of The Uncommon Individual Foundation and has been given the honorary title of Chairman Emeritus. |
| Common StockSEC Table I · non-derivative | IndirectBy The Uncommon Individual Foundation | 24,382 |
Reported balance
Holding disclosure · report date 2020-04-29 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 24,382 F1: The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. F2: Tru St Partnership, LP ("Tru St") may be deemed the beneficial owner of 1,997,068 shares of common stock. Dr. Caruso is the Chairman Emeritus of Provco Leasing Corporation ("Provco Leasing"). Provco Leasing is the corporate general partner of Tru St Partnership LP. Provco Leasing owns 7,779 shares of common stock directly and is the beneficial owner of 2,004,847 shares of common stock. The Uncommon Individual Foundation is the beneficial owner of 24,382 shares of common stock as of December 31, 2018. Dr. Caruso is the founder and chief executive officer of The Uncommon Individual Foundation. At the quarterly board meeting of The Uncommon Individual Foundation and has been given the honorary title of Chairman Emeritus. |
| Common StockSEC Table I · non-derivative | IndirectBy Provco Leasing Corporation | 7,779 |
Reported balance
Holding disclosure · report date 2020-04-29 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 7,779 F1: The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. F2: Tru St Partnership, LP ("Tru St") may be deemed the beneficial owner of 1,997,068 shares of common stock. Dr. Caruso is the Chairman Emeritus of Provco Leasing Corporation ("Provco Leasing"). Provco Leasing is the corporate general partner of Tru St Partnership LP. Provco Leasing owns 7,779 shares of common stock directly and is the beneficial owner of 2,004,847 shares of common stock. The Uncommon Individual Foundation is the beneficial owner of 24,382 shares of common stock as of December 31, 2018. Dr. Caruso is the founder and chief executive officer of The Uncommon Individual Foundation. At the quarterly board meeting of The Uncommon Individual Foundation and has been given the honorary title of Chairman Emeritus. |
Filing footnotes · ownership attribution and instrument terms
F1: The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
F2: Tru St Partnership, LP ("Tru St") may be deemed the beneficial owner of 1,997,068 shares of common stock. Dr. Caruso is the Chairman Emeritus of Provco Leasing Corporation ("Provco Leasing"). Provco Leasing is the corporate general partner of Tru St Partnership LP. Provco Leasing owns 7,779 shares of common stock directly and is the beneficial owner of 2,004,847 shares of common stock. The Uncommon Individual Foundation is the beneficial owner of 24,382 shares of common stock as of December 31, 2018. Dr. Caruso is the founder and chief executive officer of The Uncommon Individual Foundation. At the quarterly board meeting of The Uncommon Individual Foundation and has been given the honorary title of Chairman Emeritus.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 18, 2020 Filed Jun 22, 2020 20:12 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | SaleCommon Stock | 600,000 | $48.47 | $29,082,000.00 |
DisclosureSEC source: 0001209191-20-038142 · doc4.xml · nonDerivative · entry 2 CARUSO RICHARD E · CIK 0001187576 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Partnership Disclosed balance after: 10,291,205 F1 · kind: Trust Partnership contributed Issuer common stock to an exchange fund in exchange for shares of the exchange fund. The Issuer common stock was valued at $48.57 per share for the purpose of determining the number of shares of the exchange fund issuable to Trust Partnership. Read SEC document |
| April 29, 2020 Filed May 1, 2020 17:36 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | OtherStock Option (Right-to-Buy) · Derivative | 4,921 | $0.00 Strike: $9.43 | $0.00 |
DisclosureSEC source: 0001615594-20-000026 · primary_doc.xml · derivative · entry 6 CARUSO RICHARD E · CIK 0001187576 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,921 shares Expires 2020-05-15 Read SEC document |
| April 29, 2020 Filed May 1, 2020 17:36 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | SaleCommon Stock | 4,921 | $10.56 | $51,959.36 |
DisclosureSEC source: 0001615594-20-000026 · primary_doc.xml · nonDerivative · entry 2 CARUSO RICHARD E · CIK 0001187576 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,457 Read SEC document |
| April 29, 2020 Filed May 1, 2020 17:36 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | OtherCommon Stock | 4,921 | $9.43 | $46,405.03 |
DisclosureSEC source: 0001615594-20-000026 · primary_doc.xml · nonDerivative · entry 1 CARUSO RICHARD E · CIK 0001187576 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,378 Read SEC document |
| April 22, 2020 Filed Apr 24, 2020 20:29 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Exercise / conversionNon-Qualified Stock Options (right to buy) · Derivative | 13,876 | $0.00 Strike: $14.65 | $0.00 |
DisclosureSEC source: 0001209191-20-025600 · doc4.xml · derivative · entry 6 CARUSO RICHARD E · CIK 0001187576 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,876 shares Expires 2020-05-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 25% of the stock options vest every quarter from the grant date of 5/17/2012 F3 · balance_after: In accordance with the terms of the stock option plan, the exercise price of the option and number of shares subject to the option have been adjusted to reflect the two-for-one stock split that occurred on December 21, 2016. F4 · balance_after: This option was previously reported as covering 6,647 shares at an exercise price of $33.85 per share, but was adjusted pursuant to the anti-dilution provisions of the award in connection with the spin-off of SeaSpine Holdings Corporation on July 1, 2015 to 6,938 shares of common stock at an exercise price of $29.29 per share. Read SEC document |
| April 22, 2020 Filed Apr 24, 2020 20:29 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Exercise / conversionNon-Qualified Stock Options (right to buy) · Derivative | 15,658 | $0.00 Strike: $14.65 | $0.00 |
DisclosureSEC source: 0001209191-20-025600 · doc4.xml · derivative · entry 5 CARUSO RICHARD E · CIK 0001187576 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,876 Underlying: Common Stock · 15,658 shares Expires 2020-05-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 25% of the stock options vest every quarter from the grant date of 5/17/2012 F2 · balance_after: This option was previously reported as covering 7,500 shares at an exercise price of $33.85 per share, but was adjusted pursuant to the anti-dilution provisions of the award in connection with the spin-off of SeaSpine Holdings Corporation on July 1, 2015 to 7,829 shares of common stock at an exercise price of $29.29 per share. F3 · balance_after: In accordance with the terms of the stock option plan, the exercise price of the option and number of shares subject to the option have been adjusted to reflect the two-for-one stock split that occurred on December 21, 2016. Read SEC document |
| April 22, 2020 Filed Apr 24, 2020 20:29 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Exercise / conversionCommon Stock | 13,876 | $14.65 | $203,214.02 |
DisclosureSEC source: 0001209191-20-025600 · doc4.xml · nonDerivative · entry 2 CARUSO RICHARD E · CIK 0001187576 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,668 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 22, 2020 Filed Apr 24, 2020 20:29 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Exercise / conversionCommon Stock | 15,658 | $14.65 | $229,311.41 |
DisclosureSEC source: 0001209191-20-025600 · doc4.xml · nonDerivative · entry 1 CARUSO RICHARD E · CIK 0001187576 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,792 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 19, 2019 Filed Dec 20, 2019 21:08 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | SaleCommon Stock | 491,205 | $59.42 | $29,187,401.10 |
DisclosureSEC source: 0001209191-19-061524 · doc4.xml · nonDerivative · entry 2 CARUSO RICHARD E · CIK 0001187576 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Partership Disclosed balance after: 10,891,205 F1 · kind: Trust Partnership contributed Issuer common stock to an exchange fund in exchange for shares of the exchange fund. The Issuer common stock was valued at $59.42 per share for the purpose of determining the number of shares of the exchange fund issuable to Trust Partnership. Read SEC document |
| September 19, 2019 Filed Sep 20, 2019 20:56 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | SaleCommon Stock | 520,000 | $60.97 | $31,704,140.00 |
DisclosureSEC source: 0001209191-19-050354 · doc4.xml · nonDerivative · entry 2 CARUSO RICHARD E · CIK 0001187576 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Partnership Disclosed balance after: 11,382,410 F1 · kind: Trust Partnership contributed Issuer common stock to an exchange fund in exchange for shares of the exchange fund. The Issuer common stock was valued at $60.9695 per share for the purpose of determining the number of shares of the exchange fund issuable to Trust Partnership. Read SEC document |
| August 22, 2019 Filed Aug 26, 2019 20:08 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | SaleCommon Stock | 80,000 | $61.77 | $4,941,600.00 |
DisclosureSEC source: 0001209191-19-047398 · doc4.xml · nonDerivative · entry 2 CARUSO RICHARD E · CIK 0001187576 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Partership Disclosed balance after: 11,902,410 F1 · kind: Trust Partnership contributed Issuer common stock to an exchange fund in exchange for shares of the exchange fund. The Issuer common stock was valued at $61.77 per share for the purpose of determining the number of shares of the exchange fund issuable to Trust Partnership. Read SEC document |
| May 06, 2019 Filed May 8, 2019 16:22 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | OtherStock Option (right to buy) · Derivative | 5,020 | $0.00 Strike: $14.15 | $0.00 |
DisclosureSEC source: 0001637761-19-000065 · wf-form4_155734673559789.xml · derivative · entry 6 CARUSO RICHARD E · CIK 0001187576 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,020 shares Expires 2019-05-17 Read SEC document |
| May 06, 2019 Filed May 8, 2019 16:22 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | SaleCommon Stock | 5,020 | $15.17 | $76,153.40 |
DisclosureSEC source: 0001637761-19-000065 · wf-form4_155734673559789.xml · nonDerivative · entry 2 CARUSO RICHARD E · CIK 0001187576 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,457 F1 · price: The price reported is a weighted average. These shares were sold in multiple transactions at prices ranging from not less than $15.09 to not more than $15.26. The reporting person undertakes to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| May 06, 2019 Filed May 8, 2019 16:22 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | OtherCommon Stock | 5,020 | $14.15 | $71,033.00 |
DisclosureSEC source: 0001637761-19-000065 · wf-form4_155734673559789.xml · nonDerivative · entry 1 CARUSO RICHARD E · CIK 0001187576 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,477 Read SEC document |
| March 13, 2019 Filed Mar 15, 2019 21:17 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 20,878 | $0.00 Strike: $21.97 | $0.00 |
DisclosureSEC source: 0001209191-19-019753 · doc4.xml · derivative · entry 8 CARUSO RICHARD E · CIK 0001187576 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,878 shares Expires 2019-05-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 25% of the stock options vest every quarter from the grant date of 5/17/2011 F3 · balance_after: In accordance with the terms of the stock option plan, the exercise price of the option and number of shares subject to the option have been adjusted to reflect the two-for-one stock split that occurred on December 21, 2016. F4 · balance_after: This option was previously reported as covering 10,000 shares at an exercise price of $50.78 per share, but was adjusted pursuant to the anti-dilution provisions of the award in connection with the spin-off of SeaSpine Holdings Corporation on July 1, 2015 to 10,439 shares of common stock at an exercise price of $43.93 per share. Read SEC document |
| March 13, 2019 Filed Mar 15, 2019 21:17 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 9,250 | $0.00 Strike: $21.97 | $0.00 |
DisclosureSEC source: 0001209191-19-019753 · doc4.xml · derivative · entry 7 CARUSO RICHARD E · CIK 0001187576 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,878 Underlying: Common Stock · 9,250 shares Expires 2019-05-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 25% of the stock options vest every quarter from the grant date of 5/17/2011 F2 · balance_after: This option was previously reported as covering 4,431 shares at an exercise price of $50.78 per share, but was adjusted pursuant to the anti-dilution provisions of the award in connection with the spin-off of SeaSpine Holdings Corporation on July 1, 2015 to 4,625 shares of common stock at an exercise price of $43.93 per share. F3 · balance_after: In accordance with the terms of the stock option plan, the exercise price of the option and number of shares subject to the option have been adjusted to reflect the two-for-one stock split that occurred on December 21, 2016. Read SEC document |
| March 13, 2019 Filed Mar 15, 2019 21:17 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | SaleCommon Stock | 20,878 | $56.06 | $1,170,406.07 |
DisclosureSEC source: 0001209191-19-019753 · doc4.xml · nonDerivative · entry 4 CARUSO RICHARD E · CIK 0001187576 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,134 Read SEC document |
| March 13, 2019 Filed Mar 15, 2019 21:17 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Exercise / conversionCommon Stock | 20,878 | $21.97 | $458,585.27 |
DisclosureSEC source: 0001209191-19-019753 · doc4.xml · nonDerivative · entry 3 CARUSO RICHARD E · CIK 0001187576 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,012 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 13, 2019 Filed Mar 15, 2019 21:17 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | SaleCommon Stock | 9,250 | $56.06 | $518,548.53 |
DisclosureSEC source: 0001209191-19-019753 · doc4.xml · nonDerivative · entry 2 CARUSO RICHARD E · CIK 0001187576 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,134 Read SEC document |
| March 13, 2019 Filed Mar 15, 2019 21:17 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Exercise / conversionCommon Stock | 9,250 | $21.97 | $203,176.25 |
DisclosureSEC source: 0001209191-19-019753 · doc4.xml · nonDerivative · entry 1 CARUSO RICHARD E · CIK 0001187576 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,384 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 17, 2018 Filed Oct 18, 2018 20:58 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | SaleCommon Stock | 23,338 | $63.16 | $1,474,100.43 |
DisclosureSEC source: 0001209191-18-055574 · doc4.xml · nonDerivative · entry 3 CARUSO RICHARD E · CIK 0001187576 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Corporation Disclosed balance after: 0 F2 · price: The price shown above represents the weighted average price of the shares sold. The range of sale prices was $63 to $63.39. Read SEC document |
| October 16, 2018 Filed Oct 18, 2018 20:58 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | SaleCommon Stock | 23,338 | $63.22 | $1,475,419.02 |
DisclosureSEC source: 0001209191-18-055574 · doc4.xml · nonDerivative · entry 2 CARUSO RICHARD E · CIK 0001187576 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Corporation Disclosed balance after: 23,338 F1 · price: The price shown above represents the weighted average price of the shares sold. The range of sale prices was $63 to $63.57. Read SEC document |
| March 08, 2018 Filed Mar 12, 2018 20:12 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 20,878 | $0.00 Strike: $18.06 | $0.00 |
DisclosureSEC source: 0001209191-18-018856 · doc4.xml · derivative · entry 9 CARUSO RICHARD E · CIK 0001187576 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,878 shares Expires 2018-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 25% of the stock options vest every quarter from the grant date of 5/19/2010 F5 · balance_after: In accordance with the terms of the stock option plan, the exercise price of the option and number of shares subject to the option have been adjusted to reflect the two-for-one stock split that occurred on December 21, 2016. F6 · balance_after: This option was previously reported as covering 10,000 shares at an exercise price of $41.75 per share, but was adjusted pursuant to the anti-dilution provisions of the award in connection with the spin-off of SeaSpine Holdings Corporation on July 1, 2015 to 10,439 shares of common stock at an exercise price of $36.12 per share. Read SEC document |
| March 08, 2018 Filed Mar 12, 2018 20:12 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 12,002 | $0.00 Strike: $18.06 | $0.00 |
DisclosureSEC source: 0001209191-18-018856 · doc4.xml · derivative · entry 8 CARUSO RICHARD E · CIK 0001187576 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,002 shares Expires 2018-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 25% of the stock options vest every quarter from the grant date of 5/19/2010 F4 · balance_after: This option was previously reported as covering 5,749 shares at an exercise price of $41.75 per share, but was adjusted pursuant to the anti-dilution provisions of the award in connection with the spin-off of SeaSpine Holdings Corporation on July 1, 2015 to 6,001 shares of common stock at an exercise price of $36.12 per share. F5 · balance_after: In accordance with the terms of the stock option plan, the exercise price of the option and number of shares subject to the option have been adjusted to reflect the two-for-one stock split that occurred on December 21, 2016. Read SEC document |
| March 08, 2018 Filed Mar 12, 2018 20:12 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | SaleCommon Stock | 20,878 | $53.68 | $1,120,770.71 |
DisclosureSEC source: 0001209191-18-018856 · doc4.xml · nonDerivative · entry 4 CARUSO RICHARD E · CIK 0001187576 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,134 F2 · price: The price shown above represents the weighted average price of the shares sold. The range of sale prices was $53.37 to $54. Read SEC document |
| March 08, 2018 Filed Mar 12, 2018 20:12 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Exercise / conversionCommon Stock | 20,878 | $18.06 | $377,056.68 |
DisclosureSEC source: 0001209191-18-018856 · doc4.xml · nonDerivative · entry 3 CARUSO RICHARD E · CIK 0001187576 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,012 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 08, 2018 Filed Mar 12, 2018 20:12 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | SaleCommon Stock | 12,002 | $53.68 | $644,290.16 |
DisclosureSEC source: 0001209191-18-018856 · doc4.xml · nonDerivative · entry 2 CARUSO RICHARD E · CIK 0001187576 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,134 F2 · price: The price shown above represents the weighted average price of the shares sold. The range of sale prices was $53.37 to $54. Read SEC document |
| March 08, 2018 Filed Mar 12, 2018 20:12 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Exercise / conversionCommon Stock | 12,002 | $18.06 | $216,756.12 |
DisclosureSEC source: 0001209191-18-018856 · doc4.xml · nonDerivative · entry 1 CARUSO RICHARD E · CIK 0001187576 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,136 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: On December 21, 2016, the common stock of Integra LifeSciences Holdings Corporation split two-for-one, resulting in the reporting person's ownership of one additional share of common stock for each share of common stock owned as of that date, as reflected in the totals listed on this Form 4. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.